Missing/wrong data?
Log in to edit
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
scientific article published on 18 July 2014
Author/s
author: Maeve Lowery, Eileen M. O'Reilly
Work details
Publication date
July 18, 2014
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.